(Q35084790)

6 August 2017

1 reference

title

Modifiers of risk of hereditary breast and ovarian cancer (English)

1 reference

6 August 2017

1 reference

1

Steven A Narod

1 reference

PubMed ID

12635174

6 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

6 August 2017

Nature Reviews Cancer

1 reference

6 August 2017

2

1 reference

6 August 2017

113-123

1 reference

6 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc726

6 August 2017

0 references

cites work

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease

21 January 2018

1 reference

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

21 January 2018

1 reference

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer

21 January 2018

1 reference

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

21 January 2018

1 reference

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

21 January 2018

1 reference

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

21 January 2018

1 reference

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

21 January 2018

1 reference

Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk

21 January 2018

1 reference

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

21 January 2018

1 reference

No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.

21 January 2018

1 reference

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

21 January 2018

1 reference

The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development

21 January 2018

1 reference

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

21 January 2018

1 reference

Role of the human RAD51 protein in homologous recombination and double-stranded-break repair.

21 January 2018

1 reference

A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers

21 January 2018

1 reference

An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.

21 January 2018

1 reference

The electroencephalogram (EEG) as a research tool in human behavior genetics: psychological examinations in healthy males with various inherited EEG variants. I. Rationale of the study. Material. Methods. Heritability of test parameters

21 January 2018

1 reference

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study

21 January 2018

1 reference

Influence of age and parity on the development of the human breast

21 January 2018

1 reference

Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers

21 January 2018

1 reference

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

21 January 2018

1 reference

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.

21 January 2018

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

21 January 2018

1 reference

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

21 January 2018

1 reference

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

21 January 2018

1 reference

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

21 January 2018

1 reference

Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line

21 January 2018

1 reference

Genome maintenance mechanisms for preventing cancer

21 January 2018

1 reference

BRCA2 and homologous recombination

21 January 2018

1 reference

Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture.

21 January 2018

1 reference

Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent

21 January 2018

1 reference

The Kin-Cohort Study for Estimating Penetrance

21 January 2018

1 reference

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

21 January 2018

1 reference

Androgen Receptor Exon 1 CAG Repeat Length and Breast Cancer in Women Before Age Forty Years

21 January 2018

1 reference

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

21 January 2018

1 reference

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

21 January 2018

1 reference

Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2

21 January 2018

1 reference

A genetic epidemiological study of carcinoma of the fallopian tube

21 January 2018

1 reference

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

31 March 2020

1 reference

Unusual case of Smith-Lemli-Opitz syndrome "type II"

31 March 2020

1 reference

A polymorphic stop codon in BRCA2

31 March 2020

1 reference

Alleles of the estrogen receptor alpha-gene and an estrogen receptor cotranscriptional activator gene, amplified in breast cancer-1 (AIB1), are associated with quantitative calcaneal ultrasound

31 March 2020

1 reference

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus

31 March 2020

1 reference

Increasing incidence of breast cancer in family with BRCA1 mutation

31 March 2020

1 reference

Risk modifiers in carriers of brca1 mutations

31 March 2020

1 reference

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

31 March 2020

1 reference

Childbearing, oral contraceptive use, and breast cancer

31 March 2020

1 reference

Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer

31 March 2020

1 reference

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

31 March 2020

1 reference

Ovarian cancer, oral contraceptives, and BRCA mutations

31 March 2020

1 reference

Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study

31 March 2020

1 reference

Tubal ligation and risk of ovarian cancer

31 March 2020

1 reference

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

31 March 2020

1 reference

BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells

31 March 2020

1 reference

Chemopreventive agents: selenium

31 March 2020

1 reference

Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC726

1 reference

6 August 2017

1 reference

PubMed ID

12635174